Shreenivas Satya S, Rame J Eduardo, Jessup Mariell
Department of Medicine, Cardiovascular Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Curr Heart Fail Rep. 2010 Dec;7(4):159-66. doi: 10.1007/s11897-010-0026-4.
Mechanical circulatory support (MCS) frequently is used to treat medically refractory end-stage heart failure. Initially designed to be a bridge to transplantation, MCS also has proven itself as a durable therapy for patients who are not transplant candidates. As outcomes for patients with MCS have improved, research interest in device development has flourished, with many new device types under investigation. In addition to improvement of MCS devices, investigational work continues to achieve appropriate patient selection and complication management.
机械循环支持(MCS)常用于治疗药物难治性终末期心力衰竭。MCS最初设计为移植的桥梁,对于不适合移植的患者,它也已证明是一种持久的治疗方法。随着MCS患者的治疗效果有所改善,对设备开发的研究兴趣蓬勃发展,许多新型设备正在研究中。除了改进MCS设备外,研究工作还在继续,以实现合适的患者选择和并发症管理。